Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: Comparison between different methods

Journal of Endocrinological Investigation

Volumn 33, Issue 3, 2010, Pages 197-201

  Chiappori, A ^a   Villalta, D ^b   Bossert, I ^a   Ceresola, E M ^a   Lanaro, D ^a   Schiavo, M ^a   Bagnasco, M ^a   Pesce, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b AO S Maria degli Angeli   (Italy)

Author keywords

Graves' disease; Hyperthyroidism; Radioiodine therapy; Thyroid autoimmunity; Thyrotropin receptor antibodies

Indexed keywords

AUTOANTIBODY; IODINE 131; MONOCLONAL ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY DETECTION; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; EVALUATION; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; NOTE; RADIOISOTOPE THERAPY; RECEPTOR BINDING; SENSITIVITY AND SPECIFICITY;

EID: 77952823185     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346581     Document Type: Note

References (20)

1. Smith BR, Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet 1974, 2: 427-431
2. Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999, 84: 90-97 (Pubitemid 29036685)
3. Morgenthaler NG, Hodak K, Seissler J, et al. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay. Thyroid 1999, 9: 466-475 (Pubitemid 29244924)
4. Villalta D, Orunesu E, Tozzoli R, et al. Analytical and diagnostic accuracy of "second generation" assays for thyrotropin receptor antibodies with radioactive and chemiluminescent tracers. J Clin Pathol 2004, 57: 378-382
5. Smith BR, Bolton J, Young S, et al. A new assay for thyrotropin re- ceptor autoantibodies. Thyroid 2004 14: 830-835 (Pubitemid 39489008)
6. Sanders J, Allen F, Jeffreys J, et al. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid 2005, 15: 672-682 (Pubitemid 41117519)
7. Kamijo K, Ishikawa K, Tanaka M. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 2005, 52: 525-529 (Pubitemid 41609039)
8. Kim WB, Chung HK, Park YJ, et al. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid 2000, 10: 579-586
9. Sanders J, Evans M, Betterle C, et al. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid 2008, 18: 735-746 (Pubitemid 352009924)
10. Rees Smith B, Sanders J, Evans M, Tagami T, Furmaniak J. TSH receptor - autoantibody interactions. Horm Metab Res 2009, 41: 448-455
11. Massart C, Sapin R, Gibassier J, Agin A, D'Herbomez M. Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves' disease and for the follow up of Graves' ophthalmopathy. Clin Chem 2009, 55: 183-186
12. Liu C, Hermsen D, Domberg J, et al. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Horm Metab Res 2008, 40: 479-483
13. Singer PA, Cooper DS, Elliot GI, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995, 273: 808-811
14. Chiovato L, Fiore E, Vitti P, et al. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 1998, 83: 40-46 (Pubitemid 28498308)
15. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tøning O. TSH-receptor autoimunity in Graves' disease after therapy with antithyroid drugs, surgery, or radioiodine: a 5-year prospective randomised study. Eur J Endocrinol 2008, 158: 69-75. (Pubitemid 351211042)
16. Traino AC, Di Martino F, Lazzeri M, Stabin MG. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Phys Med Biol 2000, 45: 121-129 (Pubitemid 30060664)
17. Massaro F, Vera L, Schiavo M et al. Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. J Endocrinol Invest 2007, 30: 318-322 (Pubitemid 47008082)
18. Dunkelmann S, Wolf R, Koch A, et al. Incidence of radiation induced Graves'disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high sensitivity TSH receptor antibody assay. Eur J Nucl Med Mol Imaging 2004, 31: 1428-1434 (Pubitemid 39361940)
19. Chiovato L, Santini F, Vitti P, Bendinelli G, Pinchera A. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goiter. J Clin Endocrinol 1994, 40: 803-806 (Pubitemid 24216632)
20. 131I therapy. Thyroid 1999, 9: 477-481 (Pubitemid 29244925)